Adaptive Biotechnologies Corp Stock Market Value
| ADPT Stock | USD 2.34 0.10 4.10% |
| Symbol | Adaptive |
Adaptive Biotechnologies Price To Book Ratio
Is Adaptive Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adaptive Biotechnologies. If investors know Adaptive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adaptive Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.56) | Revenue Per Share 1.179 | Quarterly Revenue Growth (0.17) | Return On Assets (0.17) | Return On Equity (0.58) |
The market value of Adaptive Biotechnologies is measured differently than its book value, which is the value of Adaptive that is recorded on the company's balance sheet. Investors also form their own opinion of Adaptive Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adaptive Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adaptive Biotechnologies' market value can be influenced by many factors that don't directly affect Adaptive Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adaptive Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adaptive Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adaptive Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Adaptive Biotechnologies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Adaptive Biotechnologies' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Adaptive Biotechnologies.
| 03/20/2024 |
| 04/19/2024 |
If you would invest 0.00 in Adaptive Biotechnologies on March 20, 2024 and sell it all today you would earn a total of 0.00 from holding Adaptive Biotechnologies Corp or generate 0.0% return on investment in Adaptive Biotechnologies over 30 days. Adaptive Biotechnologies is related to or competes with Oric PharmaceuticalsI, Anebulo Pharmaceuticals, Cullinan Oncology, C4 TherapeuticsInc, Molecular Partners, Mineralys Therapeutics, and AN2 Therapeutics. Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis... More
Adaptive Biotechnologies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Adaptive Biotechnologies' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Adaptive Biotechnologies Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 26.16 | |||
| Value At Risk | (7.69) | |||
| Potential Upside | 8.96 |
Adaptive Biotechnologies Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Adaptive Biotechnologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Adaptive Biotechnologies' standard deviation. In reality, there are many statistical measures that can use Adaptive Biotechnologies historical prices to predict the future Adaptive Biotechnologies' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.91) | |||
| Total Risk Alpha | (1.28) | |||
| Treynor Ratio | (0.42) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Adaptive Biotechnologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Adaptive Biotechnologies Backtested Returns
Adaptive Biotechnologies secures Sharpe Ratio (or Efficiency) of -0.16, which signifies that the company had a -0.16% return per unit of standard deviation over the last 3 months. Adaptive Biotechnologies Corp exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Adaptive Biotechnologies' mean deviation of 4.02, and Risk Adjusted Performance of (0.09) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.93, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Adaptive Biotechnologies will likely underperform. Adaptive Biotechnologies has an expected return of -0.81%. Please make sure to confirm Adaptive Biotechnologies potential upside, and the relationship between the jensen alpha and rate of daily change , to decide if Adaptive Biotechnologies performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.62 |
Good predictability
Adaptive Biotechnologies Corp has good predictability. Overlapping area represents the amount of predictability between Adaptive Biotechnologies time series from 20th of March 2024 to 4th of April 2024 and 4th of April 2024 to 19th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Adaptive Biotechnologies price movement. The serial correlation of 0.62 indicates that roughly 62.0% of current Adaptive Biotechnologies price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.62 | |
| Spearman Rank Test | 0.17 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Adaptive Biotechnologies lagged returns against current returns
Autocorrelation, which is Adaptive Biotechnologies stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Adaptive Biotechnologies' stock expected returns. We can calculate the autocorrelation of Adaptive Biotechnologies returns to help us make a trade decision. For example, suppose you find that Adaptive Biotechnologies has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Adaptive Biotechnologies regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Adaptive Biotechnologies stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Adaptive Biotechnologies stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Adaptive Biotechnologies stock over time.
Current vs Lagged Prices |
| Timeline |
Adaptive Biotechnologies Lagged Returns
When evaluating Adaptive Biotechnologies' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Adaptive Biotechnologies stock have on its future price. Adaptive Biotechnologies autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Adaptive Biotechnologies autocorrelation shows the relationship between Adaptive Biotechnologies stock current value and its past values and can show if there is a momentum factor associated with investing in Adaptive Biotechnologies Corp.
Regressed Prices |
| Timeline |
Adaptive Biotechnologies Investors Sentiment
The influence of Adaptive Biotechnologies' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Adaptive. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Adaptive Biotechnologies' public news can be used to forecast risks associated with an investment in Adaptive. The trend in average sentiment can be used to explain how an investor holding Adaptive can time the market purely based on public headlines and social activities around Adaptive Biotechnologies Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Adaptive Biotechnologies' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Adaptive Biotechnologies' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Adaptive Biotechnologies' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Adaptive Biotechnologies.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Adaptive Biotechnologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Adaptive Biotechnologies' short interest history, or implied volatility extrapolated from Adaptive Biotechnologies options trading.
Pair Trading with Adaptive Biotechnologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adaptive Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adaptive Biotechnologies will appreciate offsetting losses from the drop in the long position's value.Moving together with Adaptive Stock
| 0.77 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
| 0.76 | ME | 23Andme Holding | PairCorr |
Moving against Adaptive Stock
| 0.87 | YS | YS Biopharma Report 22nd of April 2024 | PairCorr |
| 0.72 | DOMH | Dominari Holdings | PairCorr |
| 0.58 | VCEL | Vericel Corp Ord Downward Rally | PairCorr |
| 0.57 | A | Agilent Technologies Financial Report 28th of May 2024 | PairCorr |
| 0.52 | DNTH | Dianthus Therapeutics Symbol Change | PairCorr |
The ability to find closely correlated positions to Adaptive Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adaptive Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adaptive Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adaptive Biotechnologies Corp to buy it.
The correlation of Adaptive Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adaptive Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adaptive Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adaptive Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Adaptive Biotechnologies Correlation, Adaptive Biotechnologies Volatility and Adaptive Biotechnologies Alpha and Beta module to complement your research on Adaptive Biotechnologies. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Adaptive Stock analysis
When running Adaptive Biotechnologies' price analysis, check to measure Adaptive Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptive Biotechnologies is operating at the current time. Most of Adaptive Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adaptive Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptive Biotechnologies' price. Additionally, you may evaluate how the addition of Adaptive Biotechnologies to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |
Adaptive Biotechnologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.